AAAAAA

   
Results: 1-2 |
Results: 2
S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine,and 11 other antipsychotic agents
Authors: Millan, MJ Brocco, M Rivet, JM Audinot, V Newman-Tancredi, A Maiofiss, L Queriaux, S Despaux, N Peglion, JL Dekeyne, A
Citation: Mj. Millan et al., S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine,and 11 other antipsychotic agents, J PHARM EXP, 292(1), 2000, pp. 54-66
S-16924, a novel, potential antipsychotic with marked serotonin(1A) agonist properties. IV. A drug discrimination comparison with clozapine
Authors: Millan, MJ Schreiber, R Monneyron, S Denorme, B Melon, C Queriaux, S Dekeyne, A
Citation: Mj. Millan et al., S-16924, a novel, potential antipsychotic with marked serotonin(1A) agonist properties. IV. A drug discrimination comparison with clozapine, J PHARM EXP, 289(1), 1999, pp. 427-436
Risultati: 1-2 |